Yu Xia
Director · Summit Therapeutics Inc.
IndividualBuying only
- 2025
- Oct 23, 2025
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Yu Xia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
- Manmeet Singh Soni - $722K in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yu Xia?
Yu Xia is a corporate insider, tracked as Director of Summit Therapeutics Inc. (SMMT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Yu Xia last file a Form 4?
The only primary Form 4 on record is dated 23 October 2025.
Has Yu Xia been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10.00M) and 0 open-market sales across all tracked filings.
